EC
MIRM icon

Elequin Capital’s Mirum Pharmaceuticals MIRM Stock Holding History

Elequin Capital’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-40
Closed -$3.69K – 830
2026
Q1 		$3.69K Sell
40
-85
-68% -$8K ﹤0.01% 416
2025
Q4 		$9.87K Buy
+125
New +$8.97K ﹤0.01% 242
2024
Q4 		– Sell
-13
Closed -$507 – 590
2024
Q3 		$507 Buy
+13
New +$519 ﹤0.01% 345
2024
Q2 		– Sell
-355
Closed -$8.92K – 284
2024
Q1 		$8.92K Buy
355
+262
+282% +$7.2K ﹤0.01% 114
2023
Q4 		$2.75K Sell
93
-13
-12% -$393 ﹤0.01% 284
2023
Q3 		$3.35K Buy
+106
New +$2.9K ﹤0.01% 301

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Elequin Capital's MIRM Position: Q2 2026 in Review

Elequin Capital sold out of Mirum Pharmaceuticals (MIRM) in Q2 2026, closing a stake of 40 shares — an estimated $3.69K sold.

Elequin Capital first reported a position in MIRM in Q3 2023 and held it in 6 quarters. The position peaked at $9.87K in Q4 2025. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Elequin Capital reported no remaining Mirum Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Elequin Capital sold 40 Mirum Pharmaceuticals shares in Q2 2026, an estimated $3.69K.
  • Elequin Capital first reported a position in Mirum Pharmaceuticals in Q3 2023 and held it in 6 quarters.
  • Elequin Capital's Mirum Pharmaceuticals position peaked at $9.87K in Q4 2025.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Elequin Capital's 13F filing for Q2 2026, filed 13 Aug 2026.